ANSTO to hike nuclear medicine prices by as much as nine percent
advertisement
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Molecular Imaging Homepage

First scan in US performed with uEXPLORER Total-Body PET/CT Can scan an entire patient within 15 to 30 seconds

FDG PET better for measuring Alzheimer's cognitive function than amyloid PET (FDG) PET measures brain glucose consumption

PSMA PET/CT may beat Axumin for locating recurring prostate cancer, says study Researchers at UCLA compare imaging approaches

Progenics collabs with VA on AI research for prostate cancer treatment Apply machine learning to medical images

NNSA awards agreements to US firms for Mo-99 production Will produce with no highly-enriched uranium

New bill calls for changing reimbursement for radiopharmaceuticals Aims for greater patient access to nuclear medicine exams

Bracco Imaging to acquire Blue Earth Diagnostics for $450 million Will gain rights over Axumin

Siemens showcases works in progress at SNMMI Includes TeamPlay, syngo Virtual Cockpit and a number of AI algorithms

First dual PET isotope scans performed on living organism Discussed at SNMMI 2019 Annual Meeting

MiE showcases cardiac PET scanner, Ancoris, at SNMMI Provides simultaneous 3D cardiac PET perfusion and CFR

ANSTO is raising the price of
nuclear medicine by as much as
nine percent

ANSTO to hike nuclear medicine prices by as much as nine percent

by John R. Fischer , Staff Reporter
The Australian Nuclear Science and Technology Organisation is raising the price of nuclear medicine by as much as nine percent, according to The Australian.

The hikes to the Aussie nuclear medicine sector come despite months of production and safety issues, and follow a recent radioactive leak in June that exposed three workers at its Lucas Heights facility to radioactivity, leading to its shutdown and that of its production of Molybdenum-99.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



“The increases are modest, proportional, and reflect the ongoing cost to effectively deliver secure supplies of nuclear medicine,” said an ANSTO spokesman when confirming the price hikes to the paper, adding that the government manufacturer is “consulting with the nuclear medicine community about these changes. Where concerns have been raised, we will work through them with customers who have their own commercial imperatives.”

The leak took place on June 21 when contamination was detected on the outside of a container holding 42 milliliters of Mo-99. Two of the three workers who were exposed received a dose amount “above the statuatory limit,” confirmed an ANSTO spokesperson in a statement.

He added that “early calculations" showed the dose to be equivalent to "that of a conventional radiation therapy treatment. An occupational physician will continue to provide ongoing observation. All three workers involved are receiving ongoing support from ANSTO.”

ANSTO, which claims to have the ability to provide up to 25 percent of the global need for Mo-99, was forced around the same time last year to temporarily suspend generator production at its OPAL facility, due to a mechanical fault in its transfer conveyor. The facility sent shipments of bulk Mo-99 to Lantheus Medical Imaging Inc. (LMI) in the U.S. to be packaged in generators there as a way to offset delays, until it resumed production a month after the suspension.

The government manufacturer recently celebrated a milestone in June, with the awarding of a license to its new Nuclear Medicine (ANM) facility to begin distribution of nuclear medicine. ANSTO had been making Mo-99 there on a limited basis since April.

“This is the most advanced and safest manufacturing facility for nuclear medicine on the planet today,” ANSTO CEO Dr. Adi Paterson said in a statement at the time, adding, “this is a highly sophisticated manufacturing facility that will see the Shire contributing strongly to health outcomes for patients across Australia, and the wait has been worth it!”

An investigation into the leak is underway. ANSTO has shifted the task of supplying Mo-99 nuclear medicine to alternative facilities.

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment